rs, suggesting that the adverse cognitive effects are permanent. Other studies have consistently shown similar results." Alternatives Lead author Shelly Gray, who is director of the geriatric pharmacy program at the UW School of Pharmacy, found the link in a wide range of anticholinergics, from tricyclic